Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? - Wikidata - awgldk - TriplyDB

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

http://www.wikidata.org/entity/Q26740601

about

Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.Ipilimumab for the treatment of metastatic prostate cancer.STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer.Pathology and molecular updates in tumors of the prostate: towards a personalized approach.Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis.

P2860

Q33833475-D9BFFA9C-3025-4842-8C04-986FE84F9C53 Q39093352-882A8381-0A0B-489D-ABDF-CD565009F867 Q47225399-E90F6F07-3B97-467F-A753-D08BE893A403 Q49902128-900FB5EB-B81C-40C7-91C3-A8E085E0FA28 Q52657103-21CCC686-B935-481C-A9A1-69C6607630D5 Q52861100-3497EAED-83C7-4FF8-A126-B29056EBB28F Q55364968-64713B5B-6943-4BA1-A814-634CEEF08C77

P2860

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

http://www.wikidata.org/entity/Q26740601

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

@ast

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

@en

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

@nl

type

label

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

@ast

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

@en

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

@nl

prefLabel

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

@ast

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

@en

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

@nl

P1433

Q26740601-504374DE-EE82-49C8-AC47-2989049E7CFD

P1476

Q26740601-B06E24D1-3465-42D6-8167-F14783ACDE7E

P2093

Q26740601-08563A33-6D70-4BD0-B888-DD396C7E4200

Q26740601-0E284BA6-189A-49DE-870F-A704761FB13D

Q26740601-1B602C02-BFE9-4A28-B0E6-69D6EBF7B7DF

Q26740601-2E38B061-7025-44DD-B5D5-61550BE97C07

Q26740601-AB8F600B-9A5F-4C29-A3A9-C1582805B672

Q26740601-F8FE050B-E882-498C-8D38-291493792885

Q26740601-F950ED8C-931A-414D-A184-D5E524A75885

P2860

Q26740601-03D338AD-C4E3-48F9-9207-69AD9E3CF9EF

Q26740601-04DCF757-9926-4D63-A9C3-B679650365E2

Q26740601-05A469D1-1E46-4312-98C1-478A4D80054F

Q26740601-06400A4B-F7ED-4D1D-915C-165E0BE92B02

Q26740601-0657CE13-44B5-405C-93ED-1FEB6F24DD03

Q26740601-0A61506E-0AC4-4194-983F-17EEF516617A

Q26740601-0DD9E25F-2DDD-4C40-936D-DC031247B51E

Q26740601-0E7F1F3A-9B87-438B-B0C0-26F46894AF4F

Q26740601-157DCE5E-9487-45F6-A636-68FE87B78D42

Q26740601-1B55976F-3A73-4F1D-9A3A-20275FFDD8D1

P304

Q26740601-8318284C-1D4E-438D-997A-26CF4D62C664

P31

Q26740601-1B2D50E7-E986-4EEB-B8A4-878541CA01F5

P3181

Q26740601-1EA322CC-DA5A-4478-A665-AF11E38888D1

P356

Q26740601-4757877E-35D2-4E00-A3F8-9337003E7BED

P407

Q26740601-270C4ADE-D1E6-46D5-BE46-7027FF0221B8

P433

Q26740601-F141C74C-F531-4D89-8A82-DE41AB1C5AFA

P478

Q26740601-45E77953-F251-458C-9880-99E29447CC76

P50

Q26740601-54DB0397-E94C-48E9-A3E9-FFAED7068C43

P577

Q26740601-0D407338-214A-4C57-A574-8C84F07F714E

P698

Q26740601-DD186B2C-6907-4414-A2D7-3BF2CD81A4B6

P932

Q26740601-8289E597-180A-445D-9012-4DF0A9F5D09E

P3181

P356

P1433

Oncology reviews

P1476

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

@en

P2093

Alessandra Modena

http://www.w3.org/2001/XMLSchema#string

Chiara Ciccarese

http://www.w3.org/2001/XMLSchema#string

Francesco Massari

http://www.w3.org/2001/XMLSchema#string

Giampaolo Tortora

http://www.w3.org/2001/XMLSchema#string

Matteo Brunelli

http://www.w3.org/2001/XMLSchema#string

Michelangelo Fiorentino

http://www.w3.org/2001/XMLSchema#string

Roberto Iacovelli

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

The blockade of immune checkpoints in cancer immunotherapy

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer

Cancer immunoediting: from immunosurveillance to tumor escape

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

P304

293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2273631

http://www.w3.org/2001/XMLSchema#string

P356

10.4081/ONCOL.2016.293

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Rodolfo Montironi

P577

2016-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27471580

http://www.w3.org/2001/XMLSchema#string

P932

4943092

http://www.w3.org/2001/XMLSchema#string